IbañezBJamesSAgewallSet al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the Management of Acute Myocardial Infarction in Patients Presenting with ST-segment Elevation of the European Society of Cardiology (ESC). Eur Heart J. Epub ahead of print 26August2017. DOI: 10.1093/eurheartj/ehx393.
2.
RoffiMPatronoCColletJPet al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-segment Elevation of the European Society of Cardiology (ESC). Eur Heart J2016; 37: 267–315.
3.
KumarACannonCP.Acute coronary syndromes: diagnosis and management, part I. Mayo Clin Proc2009; 84: 917–938.
4.
SolomonCGLeeTHCookEFet al. Comparison of clinical presentation of acute myocardial infarction in patients older than 65 years of age to younger patients: the Multicenter Chest Pain Study experience. Am J Cardiol1989; 63: 772–776.
5.
MontalescotGSechtemUAchenbachSet al. 2013 ESC Guidelines on the management of stable coronary artery disease: the Task Force on the Management of Stable Coronary Artery Disease of the European Society of Cardiology. Eur Heart J2013; 34: 2949–3003.
6.
JainSTingHTBellMet al. Utility of left bundle branch block as a diagnostic criterion for acute myocardial infarction. Am J Cardiol2011; 107: 1111–1116.
7.
KontosMCAzizHAChauVQet al. Outcomes in patients with chronicity of left bundle-branch block with possible acute myocardial infarction. Am Heart J2011; 161: 698–704.
BeyguiFCastrenMBrunettiNDet al. Pre-hospital management of patients with chest pain and/or dyspnoea of cardiac origin. A position paper of the Acute Cardiovascular Care Association (ACCA) of the ESC. Eur Heart J Acute Cardiovasc Care2015. Epub ahead of print: pii: 2048872615604119.
10.
ClaeysMJAhrensISinnaevePet al. The organisation of chest pain units: position paper of the Acute Cardiovascular Care Association. Eur Heart J Acute Cardiovasc Care2017; 6: 203–211.
11.
DammanPClaytonTWallentinLet al. Effects of age on long-term outcomes after a routine invasive or selective invasive strategy in patients presenting with non-ST segment elevation acute coronary syndromes: a collaborative analysis of individual data from the FRISC II – ICTUS – RITA-3 (FIR) trials. Heart2012; 98: 207–213.
12.
AngeliFVerdecchiaPSavonittoSet al. Early invasive versus selectively invasive strategy in patients with non-ST-segment elevation acute coronary syndrome: impact of age. Catheter Cardiovasc Interv2014; 83: 686–701.
13.
SavonittoSCavalliniCPetronioASet al.;for the Italian Elderly ACS Trial Investigators. Early aggressive versus initially conservative treatment in elderly patients with non-ST-segment elevation acute coronary syndrome a randomized controlled trial. J Am Coll Cardiol Interv2012; 5: 906–916.
14.
TegnNAbdelnoorMAabergeAet al. Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial. Lancet2016; 387: 1057–1065.
15.
ArmaganijanLVAlexanderKPHuangZet al. Effect of age on efficacy and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome: insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial. Am Heart J2016; 178: 176–184.
16.
LeonardiSBhattDL. Practical considerations for cangrelor use in patients with acute coronary syndromes. Eur Heart J Acute Cardiovasc Care. Epub ahead of print 1June2017. DOI: 10.1177/2048872617707960.
17.
AlnasserSMBagaiAJollySSet al. Transradial approach for coronary angiography and intervention in the elderly: a meta-analysis of 777,841 patients. Int J Cardiol2017; 228: 45–51.
18.
ValgimigliMBuenoHByrneRAet al. 2017ESC Focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J2018; 39(3): 213–260.
19.
CostaFvan KlaverenDJamesSet al. Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials. Lancet2017; 389: 1025–1034.
20.
YehRWSecemskyEAKereiakesDJet al. Development and validation of a prediction rule for benefit and harm of dual antiplatelet therapy beyond 1 year after percutaneous coronary intervention. JAMA2016; 315: 1735–1749.
21.
LeonardiSFrigoliERothenbühlerMet al. Bivalirudin or unfractionated heparin in patients with acute coronary syndromes managed invasively with and without ST elevation (MATRIX): randomised controlled trial. BMJ2016; 354: i4935.
22.
FerriLAMoriciNGrossetoDet al. A comparison of reduced-dose prasugrel and standard-dose clopidogrel in elderly patients with acute coronary syndromes undergoing early percutaneous revascularization: design and rationale of the randomized Elderly-ACS 2 study. Am Heart J2016; 181: 101–106.
23.
QaderdanKIshakMHeestermansAAet al. Ticagrelor or prasugrel versus clopidogrel in elderly patients with an acute coronary syndrome: optimization of antiplatelet treatment in patients 70 years and older – rationale and design of the POPular AGE study. Am Heart J2015; 170: 981–985.
24.
RoccaWABoydCMGrossardtBRet al. Prevalence of multimorbidity in a geographically defined American population: patterns by age, sex, and race/ethnicity. Mayo Clin Proc2014; 89: 1336–1349.
25.
AfilaloJAlexanderKPMackMJet al. Frailty assessment in the cardiovascular care of older adults. J Am Coll Cardiol2014; 63: 747–762.
26.
SinghMStewartRWhiteH.Importance of frailty in patients with cardiovascular disease. Eur Heart J2014; 35: 1726–1731.
27.
Alonso SalinasGLSanmartinMPascual IzcoMet al. Frailty is an independent prognostic marker in elderly patients with myocardial infarction. Clin Cardiol2017; 40: 925–931.
28.
DenfeldQEWinters-StoneKMuddJOet al. The prevalence of frailty in heart failure: a systematic review and meta-analysis. Int J Cardiol2017; 236: 283–289.
29.
BibasLLeviMTouchetteJet al. Implications of frailty in elderly patients with electrophysiological conditions. JACC: Clin Electrophysiol2016; 2: 288–294.
30.
RockwoodKSongXMacKnightCet al. A global clinical measure of fitness and frailty in elderly people. CMAJ2005; 173: 489–495.
31.
RockwoodKMitnitskiA.Frailty defined by deficit accumulation and geriatric medicine defined by frailty. Clin Geriatr Med2011; 27: 17–26.
32.
RichMWChyunDASkolnickAHet al. Knowledge gaps in cardiovascular care of the older adult population: a scientific statement from the American Heart Association, American College of Cardiology, and American Geriatrics Society. J Am Coll Cardiol2016; 67: 2419–2440.
33.
Le GuenJBoumendilAGuidetBet al. Are elderly patients’ opinions sought before admission to an intensive care unit? Results of the ICE-CUB study. Age Ageing2016; 45: 303–309.
34.
ZweibelNRCasselCK.Treatment choices at the end of life: a comparison of decisions by older patients and their physician-selected proxies. Gerontologist1989; 29: 615–621.